Hernia mesh under the microscope: 5-Year study launched
NCT ID NCT05094089
First seen Jan 21, 2026 · Last updated Jun 22, 2026 · Updated 18 times
Summary
This study follows 320 people who had ventral or incisional hernia repair using GORE SYNECOR biomaterial. Researchers will track hernia recurrence, infections, and other complications over 5 years. The goal is to see how well the mesh performs in the long run for different patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERNIA, VENTRAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bon Secours Memorial Regional Medical Center
Mechanicsville, Virginia, 23116, United States
-
Corewell Health
Grand Rapids, Michigan, 49506, United States
-
Emory Saint Joseph's Hospital
Atlanta, Georgia, 30342, United States
-
Hospital Quirón Salud-Sagrado Corazón
Seville, 41013, Spain
-
Lovelace Women's Hospital
Albuquerque, New Mexico, 87109, United States
-
Novant Health New Hanover Regional Medical Center
Wilmington, North Carolina, 28401, United States
-
Ospedale Civile di Baggiovara
Baggiovara, 41126, Italy
-
Prisma Health Greenville Memorial Hospital
Greenville, South Carolina, 29605, United States
-
Sapienza Università di Roma
Roma, 00189, Italy
-
Stony Brook University Hospital
Stony Brook, New York, 11794, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
University Hospital Virgen Macarena - Department of General And Digestive Surgery
Seville, 41009, Spain
-
University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital Birmingham
Birmingham, B15 2GW, United Kingdom
-
Vincenzo Monaldi Hospital
Naples, 80131, Italy
-
Walsall Manor Hospital
Walsall, WS2 9PS, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE® SYNECOR Biomaterial (hernia repair mesh)
What this could lead to
If successful, this could confirm that the mesh is safe and effective for long-term hernia repair in specific patient groups.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove the mesh is better than others. Hernia recurrence or complications like infection are still possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.